VISX INC 4
4 · VISX INC · Filed Jun 1, 2005
Insider Transaction Report
Form 4
VISX INCEYE
PETERSMEYER GARY S
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2005-05-27−10,000→ 0 total(indirect: See Footnote)Exercise: $17.06Exp: 2013-05-23→ Common Stock (10,000 underlying) - Disposition to Issuer
Phantom Stock (Right to Aquire)
2005-05-27−657→ 0 total(indirect: See Footnote)→ Common Stock (657 underlying) - Disposition to Issuer
Common Stock
2005-05-27−7,357→ 0 total(indirect: See Footnote) - Disposition to Issuer
Stock Option (Right to Buy)
2005-05-27−19,043→ 0 total(indirect: See Footnote)Exercise: $13.23Exp: 2011-12-12→ Common Stock (19,043 underlying) - Disposition to Issuer
Phantom Stock (Right to Aquire)
2005-05-27−880→ 0 total(indirect: See Footnote)→ Common Stock (880 underlying)
Footnotes (8)
- [F1]Disposed of pursuant to merger agreement between issuer and Advanced Medical Optics, Inc. in exchange for 4,061 shares of Advanced Medical Optics, Inc. common stock on the effective date of the merger.
- [F2]The shares are held by The Gary and Catherine Petersmeyer Trust dated November 9, 1999 of which the Reporting Person serves as Trustee.
- [F3]This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of December 12, 2001, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 12,230 shares of Advanced Medical Optics, Inc. common stock for $20.61 per share.
- [F4]This option, which was fully vested as of the grant date of May 23, 2003, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 6,422 shares of Advanced Medical Optics, Inc. common stock for $26.57 per share.
- [F5]The phantom stock was credited to the Reporting Person's account under the 1995 Director Option and Stock Deferral Plan and upon exercise will be settled in common stock on a 1-for-1 basis.
- [F6]This right, which becomes payable in common stock following the Reporting Person's termination of service as a director, in accordance with the deferral election made by the Reporting Person pursuant to the 1995 Director Option and Stock Deferral Plan, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with 565 shares of Advanced Medical Optics, Inc. common stock for $26.58 per share.
- [F7]This option, which was fully vested as of the grant date of May 13, 2004, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 6,422 shares of Advanced Medical Optics, Inc. common stock for $35.57 per share.
- [F8]This right, which becomes payable in common stock following the Reporting Person's termination of service as a director, in accordance with the deferral election made by the Reporting Person pursuant to the 1995 Director Option and Stock Deferral Plan, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with 421 shares of Advanced Medical Optics, Inc. common stock for $35.65 per share.